| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Agen Brian Jon | VP, CHRO | 1500 DEKOVEN AVE., RACINE | /s/ Erin J. Roth, Attorney-in-Fact | 31 Jul 2025 | 0001729366 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOD | Common stock | Options Exercise | $108,867 | +6,847 | +7.6% | $15.90 | 96,862 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Options Exercise | $118,910 | +6,643 | +6.9% | $17.90 | 103,505 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Options Exercise | $129,139 | +9,739 | +9.4% | $13.26 | 113,244 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Options Exercise | $81,168 | +12,261 | +11% | $6.62 | 125,505 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Options Exercise | $90,996 | +5,115 | +4.1% | $17.79 | 130,620 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Options Exercise | $90,062 | +7,334 | +5.6% | $12.28 | 137,954 | 29 Jul 2025 | Direct | F1, F2 |
| transaction | MOD | Common stock | Sale | $4,557,074 | -41,304 | -30% | $110.33 | 96,650 | 29 Jul 2025 | Direct | F1, F2, F3 |
| transaction | MOD | Common stock | Sale | $735,045 | -6,590 | -6.8% | $111.54 | 90,060 | 29 Jul 2025 | Direct | F1, F2, F4 |
| transaction | MOD | Common stock | Sale | $5,062 | -45 | -0.05% | $112.49 | 90,015 | 29 Jul 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +6,847 | $0.000000 | 0 | 29 Jul 2025 | Common stock | 6,847 | $15.90 | Direct | F1 | |
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +6,643 | $0.000000 | 0 | 29 Jul 2025 | Common stock | 6,643 | $17.90 | Direct | F1 | |
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +9,739 | $0.000000 | 0 | 29 Jul 2025 | Common stock | 9,739 | $13.26 | Direct | F1 | |
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +12,261 | $0.000000 | 4,090 | 29 Jul 2025 | Common stock | 12,261 | $6.62 | Direct | F1, F5 | |
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +5,115 | $0.000000 | 1,706 | 29 Jul 2025 | Common stock | 5,115 | $17.79 | Direct | F1, F6 | |
| transaction | MOD | Employee stock option (Right to buy) | Options Exercise | $0 | +7,334 | $0.000000 | 3,779 | 29 Jul 2025 | Common stock | 7,334 | $12.28 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | The reported transactions were completed pursuant to a trading plan entered into by Mr. Agen on December 18, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This completes the activity under that plan. |
| F2 | This total includes 1474 units of Modine common stock held in the Reporting Person's Modine 401(k) Retirement Plan account. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.96, inclusive. The reporting person undertakes to provide to Modine Manufacturing Company, any security holder of Modine Manufacturing Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $112.00, inclusive. The reporting person undertakes to provide to Modine Manufacturing Company, any security holder of Modine Manufacturing Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. |
| F5 | This option vested in four equal installments on October 2, 2021, 2022, 2023, and 2024. |
| F6 | This option vested in four equal installments on June 4, 2022, 2023, 2024, and 2025. |
| F7 | This option vested as follows: 33% on June 6, 2023, 33% on June 6, 2024 and the remaining 34% on June 6, 2025. |